Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Income

v3.25.4
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 5,037.5 $ 4,993.1 $ 5,062.4
Cost of sales 1,114.6 1,104.3 1,191.0
Gross profit 3,922.9 3,888.8 3,871.4
Selling expenses 1,782.4 1,782.8 1,824.2
General and administrative expenses 1,664.3 1,725.6 1,701.0
Other operating income (4.8) (5.5) (10.2)
Operating income 481.0 385.9 356.4
Interest expense 214.4 218.3 165.9
Interest income 8.5 12.3 11.5
Other expense (income), net 0.0 10.5 (1.0)
Income before income taxes 275.1 169.4 203.0
Income taxes 47.3 (84.9) 60.8
Net Income 227.8 254.3 142.2
Net loss attributable to noncontrolling interest (0.5) 0.0 0.0
Net income attributable to Herbalife $ 228.3 $ 254.3 $ 142.2
Earnings per share attributable to Herbalife:      
Basic $ 2.22 $ 2.53 $ 1.44
Diluted $ 2.2 $ 2.5 $ 1.42
Weighted-average shares outstanding:      
Basic 102.8 100.6 99.0
Diluted 103.6 101.6 100.2